Literature DB >> 18040795

Impact of opiate-HIV-1 interactions on neurotoxic signaling.

Kurt F Hauser1, Nazira El-Hage, Shreya Buch, Avindra Nath, William R Tyor, Annadora J Bruce-Keller, Pamela E Knapp.   

Abstract

Opiate drug abuse exacerbates the pathogenesis of human immunodeficiency virus-1 (HIV-1) in the central nervous system through direct actions on glia and neurons. Opiate abuse causes widespread disruption of astroglial and microglial function, and significant increases in astroglial-derived proinflammatory cytokines and chemokines, which likely contributes to neuronal dysfunction, death, and HIV encephalitis. Neurons are also directly affected by opiate-HIV-1 interactions. HIV-1 and the viral proteins gp120 and Tat activate multiple caspase-dependent and caspase-independent proapoptotic pathways in neurons involving phosphatidylinositol 3-kinase (PI3 kinase)/Akt, as well as p38, c-Jun N-terminal kinase (JNK) and/or other mitogen-activated protein kinases (MAPKs). Opiates appear to decrease the threshold for HIV-1-mediated neurotoxicity by sending convergent signals that exacerbate proapoptotic events induced by viral and cellular toxic products. The synergistic proinflammatory and neurotoxic effects of opiate drugs on glia and neurons are largely mediated through mu opioid receptors, which are expressed by subpopulations of astroglia, microglia, and neurons. Opiate abuse intrinsically modifies the host response to HIV-1. Identification of how this occurs is providing considerable insight toward understanding the mechanisms underlying HIV-1-associated dementia.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 18040795     DOI: 10.1007/s11481-005-9000-4

Source DB:  PubMed          Journal:  J Neuroimmune Pharmacol        ISSN: 1557-1890            Impact factor:   7.285


  90 in total

1.  PTEN modulates cell cycle progression and cell survival by regulating phosphatidylinositol 3,4,5,-trisphosphate and Akt/protein kinase B signaling pathway.

Authors:  H Sun; R Lesche; D M Li; J Liliental; H Zhang; J Gao; N Gavrilova; B Mueller; X Liu; H Wu
Journal:  Proc Natl Acad Sci U S A       Date:  1999-05-25       Impact factor: 11.205

2.  Linkage of G protein-coupled receptors to the MAPK signaling pathway through PI 3-kinase gamma.

Authors:  M Lopez-Ilasaca; P Crespo; P G Pellici; J S Gutkind; R Wetzker
Journal:  Science       Date:  1997-01-17       Impact factor: 47.728

3.  Induction of apoptosis by ASK1, a mammalian MAPKKK that activates SAPK/JNK and p38 signaling pathways.

Authors:  H Ichijo; E Nishida; K Irie; P ten Dijke; M Saitoh; T Moriguchi; M Takagi; K Matsumoto; K Miyazono; Y Gotoh
Journal:  Science       Date:  1997-01-03       Impact factor: 47.728

Review 4.  Molecular targets of opiate drug abuse in neuroAIDS.

Authors:  K F Hauser; N El-Hage; S Buch; J R Berger; W R Tyor; A Nath; A J Bruce-Keller; P E Knapp
Journal:  Neurotox Res       Date:  2005-10       Impact factor: 3.911

5.  Induction of monocyte chemoattractant protein-1 in HIV-1 Tat-stimulated astrocytes and elevation in AIDS dementia.

Authors:  K Conant; A Garzino-Demo; A Nath; J C McArthur; W Halliday; C Power; R C Gallo; E O Major
Journal:  Proc Natl Acad Sci U S A       Date:  1998-03-17       Impact factor: 11.205

6.  Activation of the stress-activated MAP kinase, p38, but not JNK in cortical motor neurons during early presymptomatic stages of amyotrophic lateral sclerosis in transgenic mice.

Authors:  Silvina S Holasek; Thomas M Wengenack; Karunya K Kandimalla; Carolina Montano; Dawn M Gregor; Geoffry L Curran; Joseph F Poduslo
Journal:  Brain Res       Date:  2005-04-25       Impact factor: 3.252

7.  Negative regulation of PKB/Akt-dependent cell survival by the tumor suppressor PTEN.

Authors:  V Stambolic; A Suzuki; J L de la Pompa; G M Brothers; C Mirtsos; T Sasaki; J Ruland; J M Penninger; D P Siderovski; T W Mak
Journal:  Cell       Date:  1998-10-02       Impact factor: 41.582

8.  Lithium ameliorates HIV-gp120-mediated neurotoxicity.

Authors:  Ian P Everall; Christopher Bell; Margaret Mallory; Dianne Langford; Anthony Adame; Edward Rockestein; Eliezer Masliah
Journal:  Mol Cell Neurosci       Date:  2002-11       Impact factor: 4.314

9.  Evidence for neurotoxic activity of tat from human immunodeficiency virus type 1.

Authors:  J M Sabatier; E Vives; K Mabrouk; A Benjouad; H Rochat; A Duval; B Hue; E Bahraoui
Journal:  J Virol       Date:  1991-02       Impact factor: 5.103

10.  Kappa-opioid modulation of human microglial cell superoxide anion generation.

Authors:  S Hu; P K Peterson; C C Chao
Journal:  Biochem Pharmacol       Date:  1998-08-01       Impact factor: 5.858

View more
  40 in total

Review 1.  Effects of opiates and HIV proteins on neurons: the role of ferritin heavy chain and a potential for synergism.

Authors:  Lindsay Festa; Olimpia Meucci
Journal:  Curr HIV Res       Date:  2012-07       Impact factor: 1.581

2.  CCR2 mediates increases in glial activation caused by exposure to HIV-1 Tat and opiates.

Authors:  Nazira El-Hage; Guanghan Wu; Jayakrishna Ambati; Annadora J Bruce-Keller; Pamela E Knapp; Kurt F Hauser
Journal:  J Neuroimmunol       Date:  2006-07-10       Impact factor: 3.478

Review 3.  HIV-1 neuropathogenesis: glial mechanisms revealed through substance abuse.

Authors:  Kurt F Hauser; Nazira El-Hage; Anne Stiene-Martin; William F Maragos; Avindra Nath; Yuri Persidsky; David J Volsky; Pamela E Knapp
Journal:  J Neurochem       Date:  2006-12-01       Impact factor: 5.372

4.  Neuronal ferritin heavy chain and drug abuse affect HIV-associated cognitive dysfunction.

Authors:  Jonathan Pitcher; Anna Abt; Jaclyn Myers; Rachel Han; Melissa Snyder; Alessandro Graziano; Lindsay Festa; Michele Kutzler; Fernando Garcia; Wen-Jun Gao; Tracy Fischer-Smith; Jay Rappaport; Olimpia Meucci
Journal:  J Clin Invest       Date:  2014-01-09       Impact factor: 14.808

Review 5.  Disruption of neuronal CXCR4 function by opioids: preliminary evidence of ferritin heavy chain as a potential etiological agent in neuroAIDS.

Authors:  Jonathan Pitcher; Saori Shimizu; Silvia Burbassi; Olimpia Meucci
Journal:  J Neuroimmunol       Date:  2010-06-08       Impact factor: 3.478

6.  Critical Role of Beclin1 in HIV Tat and Morphine-Induced Inflammation and Calcium Release in Glial Cells from Autophagy Deficient Mouse.

Authors:  Jessica Lapierre; Myosotys Rodriguez; Chet Raj Ojha; Nazira El-Hage
Journal:  J Neuroimmune Pharmacol       Date:  2018-05-11       Impact factor: 4.147

Review 7.  Epigenetics, drugs of abuse, and the retroviral promoter.

Authors:  Jasmine Shirazi; Sonia Shah; Divya Sagar; Michael R Nonnemacher; Brian Wigdahl; Zafar K Khan; Pooja Jain
Journal:  J Neuroimmune Pharmacol       Date:  2013-11-12       Impact factor: 4.147

8.  CCL5/RANTES gene deletion attenuates opioid-induced increases in glial CCL2/MCP-1 immunoreactivity and activation in HIV-1 Tat-exposed mice.

Authors:  Nazira El-Hage; Annadora J Bruce-Keller; Pamela E Knapp; Kurt F Hauser
Journal:  J Neuroimmune Pharmacol       Date:  2008-09-25       Impact factor: 4.147

Review 9.  The effects of cocaine on HIV transcription.

Authors:  Mudit Tyagi; Jaime Weber; Michael Bukrinsky; Gary L Simon
Journal:  J Neurovirol       Date:  2015-11-16       Impact factor: 2.643

10.  Neuronal toxicity in HIV CNS disease.

Authors:  Jane Kovalevich; Dianne Langford
Journal:  Future Virol       Date:  2012-07-01       Impact factor: 1.831

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.